Edward P. Jordan - Net Worth and Insider Trading

Edward P. Jordan Net Worth

The estimated net worth of Edward P. Jordan is at least $6,878 dollars as of 2024-04-29. Edward P. Jordan is the SVP, Sales and Marketing of AMAG Pharmaceuticals Inc and owns about 500 shares of AMAG Pharmaceuticals Inc (AMAG) stock worth over $6,875. Edward P. Jordan is also the Chief Commercial Officer of Humanigen Inc and owns about 12,500 shares of Humanigen Inc (HGENQ) stock worth over $3. Details can be seen in Edward P. Jordan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Edward P. Jordan has not made any transactions after 2022-03-02 and currently still holds the listed stock(s).

Transaction Summary of Edward P. Jordan

To

Edward P. Jordan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edward P. Jordan owns 2 companies in total, including Humanigen Inc (HGENQ) , and AMAG Pharmaceuticals Inc (AMAG) .

Click here to see the complete history of Edward P. Jordan’s form 4 insider trades.

Insider Ownership Summary of Edward P. Jordan

Ticker Comapny Transaction Date Type of Owner
HGENQ Humanigen Inc 2022-03-02 Chief Commercial Officer
AMAG AMAG Pharmaceuticals Inc 2015-03-03 SVP & Sales and Marketing

Edward P. Jordan Latest Holdings Summary

Edward P. Jordan currently owns a total of 2 stocks. Among these stocks, Edward P. Jordan owns 500 shares of AMAG Pharmaceuticals Inc (AMAG) as of February 24, 2014, with a value of $6,875 and a weighting of 99.96%. Edward P. Jordan also owns 12,500 shares of Humanigen Inc (HGENQ) as of March 2, 2022, with a value of $3 and a weighting of 0.04%.

Latest Holdings of Edward P. Jordan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMAG AMAG Pharmaceuticals Inc 2014-02-24 500 13.75 6,875
HGENQ Humanigen Inc 2022-03-02 12,500 0.00 3

Holding Weightings of Edward P. Jordan


Edward P. Jordan Form 4 Trading Tracker

According to the SEC Form 4 filings, Edward P. Jordan has made a total of 0 transactions in AMAG Pharmaceuticals Inc (AMAG) over the past 5 years. The most-recent trade in AMAG Pharmaceuticals Inc is the sale of 0 shares on February 24, 2014, which brought Edward P. Jordan around $0.

According to the SEC Form 4 filings, Edward P. Jordan has made a total of 2 transactions in Humanigen Inc (HGENQ) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Humanigen Inc is the acquisition of 12,500 shares on March 2, 2022, which cost Edward P. Jordan around $29,000.

Insider Trading History of Edward P. Jordan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edward P. Jordan Trading Performance

GuruFocus tracks the stock performance after each of Edward P. Jordan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edward P. Jordan is -9.88%. GuruFocus also compares Edward P. Jordan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edward P. Jordan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Edward P. Jordan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Edward P. Jordan

Average Return

-93.86%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 25.93 -9.88 -90.74 -93.86 -99.36
Relative Return to S&P 500(%) 22.3 -5.1 -80.2 -84.62 -107.58

Edward P. Jordan Ownership Network

Ownership Network List of Edward P. Jordan

No Data

Ownership Network Relation of Edward P. Jordan


Edward P. Jordan Owned Company Details

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

Edward P. Jordan is the Chief Commercial Officer of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and 10 percent owner Black Horse Capital Lp .

Humanigen Inc (HGENQ) Insider Trades Summary

Over the past 18 months, Edward P. Jordan made no insider transaction in Humanigen Inc (HGENQ). Other recent insider transactions involving Humanigen Inc (HGENQ) include a net sale of 386,350 shares made by Dale Chappell ,

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 386,350 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 386,350 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Humanigen Inc Insider Transactions

No Available Data

Edward P. Jordan Mailing Address

Above is the net worth, insider trading, and ownership report for Edward P. Jordan. You might contact Edward P. Jordan via mailing address: C/o Amag Pharmaceuticals, Inc., 1100 Winter Street, Waltham Ma 02451.

Discussions on Edward P. Jordan

No discussions yet.